Moreover, Naph retains its inhibitory potential against chemotaxis of IMs toward CCL2–expressing cancer cells and the surrounding stromal cells, thereby reducing the expression of E-selectin in metastatic lung cancers without marked adverse effects. This evidence concerns the gene CCL2 and cancer.